A blood clot death was reported in NSW, which is thought to be probably related to the AstraZeneca vaccine received.
It is about a 52-year-old woman, who experienced a severe form of TTS in the form of a blood clot in the brain, also known as cerebral venous sinus thrombosis, the Australian Drug Regulatory Authority (TGA) announced.
According to the TGA report, since last week, there have been four confirmed cases of thrombosis with thrombocytopenia syndrome (TTS), which are probably related to the AstraZeneca vaccine. The deceased woman was the youngest of the four, the other people were older: a 77-year-old from New South Wales, a 70-year-old and an 87-year-old woman from South Australia.
So far, a total of 48 cases of TTS have been reported in Australia out of the 3.6 million doses given after receiving the Astra Zeneca vaccine, of which 35 have been confirmed and 13 assessed as probable.
So far, 31 people have been discharged from the hospital and are recovering, 15 patients are in the hospital, including one in critical condition who is in intensive care, while two people have died in the hospital.
Australia’s chief health officer Paul Kelly reminded that blood clotting is an “extremely rare reaction”, while the TGA said that the benefits of the Astra Zeneca vaccine still outweigh the risks.
Symptoms
TTS symptoms usually manifest between four and 30 days after vaccination. Anyone who is vaccinated should seek medical attention immediately if they begin to suffer from severe or persistent headaches, blurred vision, difficulty breathing, chest pain, swelling of the legs, persistent abdominal pain, unusual skin bruises or spots on the skin outside the vaccination site.
The article The Second AstraZenek-Related Death appears first on News Online.
Comments are closed.